v3.26.1
Note 10 - Segment Information (Tables)
6 Months Ended
Jun. 30, 2026
Notes Tables  
Segment Reporting [Table Text Block]
   

Three months ended June 30,

   

Six months ended June 30,

 
   

2026

   

2025

   

2026

   

2025

 

Revenue

  $     $     $     $ (27 )

Employee expense (not including stock-based compensation)

    1,537       1,634       3,172       2,972  

Development and clinical trial expense

    973       732       1,892       1,190  

Other general and administrative expense(a)

    818       1,151       1,894       2,078  

Other segment loss (income), net(b)

    984       (28 )     (90 )     (58 )

Discontinued operations

                      (73 )

Segment and condensed consolidated net loss

  $ (4,312 )   $ (3,489 )   $ (6,868 )   $ (6,082 )